# Mobile health applications in the management of hyperglycemia in pregnancy: a mini-review of current tools and future perspectives

**Authors:** Fanny Valsecchi, Annalisa Giancaterini, Erika Pedone, Amelia Caretto

PMC · DOI: 10.3389/fcdhc.2026.1761584 · Frontiers in Clinical Diabetes and Healthcare · 2026-03-02

## TL;DR

Mobile health apps help manage high blood sugar during pregnancy, improving outcomes for mothers and babies.

## Contribution

This mini-review highlights current mHealth tools and proposes future digital systems integrating sensors and AI for better HIP management.

## Key findings

- mHealth apps improve glycemic control and reduce maternal and fetal risks in HIP.
- Apps with AI coaching and remote monitoring enhance patient adherence and perinatal outcomes.
- Challenges include lack of clinical validation and data security concerns.

## Abstract

Hyperglycemia in pregnancy (HIP), encompassing gestational diabetes mellitus (GDM) and pre-gestational diabetes mellitus (PGDM), constitutes a growing clinical challenge, impacting approximately 23 million live births annually worldwide and conferring substantial maternal and fetal risks. This mini-review evaluates mobile health (mHealth) applications for HIP management, focusing on glycemic monitoring, nutritional interventions, physical activity promotion, insulin dose titration, and postpartum surveillance. Reviewed applications facilitate data collection from glucometers and continuous glucose monitoring systems, deliver graphical analytics, tailored recommendations, artificial intelligence-driven coaching, and secure remote data exchange with healthcare professionals, thereby increasing patient adherence, glycemic regulation, and perinatal outcomes, including reductions in HbA1c, neonatal birthweight, and caesarean section rates. Key benefits include enhanced patient empowerment, streamlined telemedicine, and psychosocial support, supported by trials demonstrating superior glycemic indices and reduced hyperglycemic excursions. Nonetheless, challenges persist, including heterogeneous clinical validation, socioeconomic-digital disparities, data security imperatives, and the absence of comprehensive integrated platforms. Future perspectives focus on developing digital systems that combine sensors, artificial intelligence, and online clinics. These systems aim to improve coordinated care for women with HIP, make treatment more effective, enhance user satisfaction, and help healthcare providers use resources efficiently.

## Linked entities

- **Diseases:** gestational diabetes mellitus (MONDO:0005406)

## Full-text entities

- **Genes:** INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}
- **Diseases:** GDM (MESH:D016640), Hyperglycemia (MESH:D006943), hyperglycemic (MESH:D006944)
- **Chemicals:** glucose (MESH:D005947)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12989348/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12989348/full.md

## References

77 references — full list in the complete paper: https://tomesphere.com/paper/PMC12989348/full.md

---
Source: https://tomesphere.com/paper/PMC12989348